U.S. Healthcare Services Stock News

NasdaqGM:IVVD
NasdaqGM:IVVDBiotechs

A Look at Invivyd (IVVD) Valuation Following New RSV Antibody Advancement and Regulatory Progress

Invivyd (IVVD) has caught investor attention after revealing a new monoclonal antibody candidate targeting RSV prevention for infants and children. This scientific milestone builds on the company’s pipeline momentum and ongoing advances in infectious disease therapeutics. See our latest analysis for Invivyd. Invivyd’s recent advancements, notably with its RSV antibody nomination and FDA emergency use authorization for another candidate, have driven market sentiment higher. The stock’s 30-day...
NYSE:HI
NYSE:HIMachinery

How Investors May Respond To Hillenbrand (HI) Achieving Profit Growth Despite Lower Sales

Hillenbrand reported its fourth quarter and full-year earnings for the period ended September 30, 2025, revealing fourth quarter sales of US$652.1 million and a quarterly net income of US$75.7 million, compared to US$837.6 million in sales and US$14.6 million in net income a year ago. Despite a decline in annual sales, the company's transition from a net loss to net income signals significant operational improvements over the past year. We'll explore how the sharp turnaround in net income...